216 related articles for article (PubMed ID: 21525003)
41. The middle portion in the second cytoplasmic loop of the thyrotropin receptor plays a crucial role in adenylate cyclase activation.
Kosugi S; Kohn LD; Akamizu T; Mori T
Mol Endocrinol; 1994 Apr; 8(4):498-509. PubMed ID: 7914349
[TBL] [Abstract][Full Text] [Related]
42. The thyrotropin (TSH) receptor transmembrane domain mutation (Pro556-Leu) in the hypothyroid hyt/hyt mouse results in plasma membrane targeting but defective TSH binding.
Gu WX; Du GG; Kopp P; Rentoumis A; Albanese C; Kohn LD; Madison LD; Jameson JL
Endocrinology; 1995 Jul; 136(7):3146-53. PubMed ID: 7789342
[TBL] [Abstract][Full Text] [Related]
43. Principles and determinants of G-protein coupling by the rhodopsin-like thyrotropin receptor.
Kleinau G; Jaeschke H; Worth CL; Mueller S; Gonzalez J; Paschke R; Krause G
PLoS One; 2010 Mar; 5(3):e9745. PubMed ID: 20305779
[TBL] [Abstract][Full Text] [Related]
44. Cleavage of the human thyrotropin receptor by ADAM10 is regulated by thyrotropin.
Kaczur V; Puskas LG; Nagy ZU; Miled N; Rebai A; Juhasz F; Kupihar Z; Zvara A; Hackler L; Farid NR
J Mol Recognit; 2007; 20(5):392-404. PubMed ID: 18074395
[TBL] [Abstract][Full Text] [Related]
45. Identification of a novel epitope in the thyroid-stimulating hormone receptor ectodomain acting as intramolecular signaling interface.
Kleinau G; Jäschke H; Neumann S; Lättig J; Paschke R; Krause G
J Biol Chem; 2004 Dec; 279(49):51590-600. PubMed ID: 15345720
[TBL] [Abstract][Full Text] [Related]
46. A free carboxylate oxygen in the side chain of position 674 in transmembrane domain 7 is necessary for TSH receptor activation.
Neumann S; Krause G; Chey S; Paschke R
Mol Endocrinol; 2001 Aug; 15(8):1294-305. PubMed ID: 11463854
[TBL] [Abstract][Full Text] [Related]
47. A conserved Asn in transmembrane helix 7 is an on/off switch in the activation of the thyrotropin receptor.
Govaerts C; Lefort A; Costagliola S; Wodak SJ; Ballesteros JA; Van Sande J; Pardo L; Vassart G
J Biol Chem; 2001 Jun; 276(25):22991-9. PubMed ID: 11312274
[TBL] [Abstract][Full Text] [Related]
48. Somatic mutations in the thyrotropin receptor gene and not in the Gs alpha protein gene in 31 toxic thyroid nodules.
Führer D; Holzapfel HP; Wonerow P; Scherbaum WA; Paschke R
J Clin Endocrinol Metab; 1997 Nov; 82(11):3885-91. PubMed ID: 9360556
[TBL] [Abstract][Full Text] [Related]
49. Lysine 183 and glutamic acid 157 of the TSH receptor: two interacting residues with a key role in determining specificity toward TSH and human CG.
Smits G; Govaerts C; Nubourgh I; Pardo L; Vassart G; Costagliola S
Mol Endocrinol; 2002 Apr; 16(4):722-35. PubMed ID: 11923469
[TBL] [Abstract][Full Text] [Related]
50. Effects of TSH receptor mutations on binding and biological activity of monoclonal antibodies and TSH.
Sanders J; Bolton J; Sanders P; Jeffreys J; Nakatake N; Richards T; Evans M; Kiddie A; Summerhayes S; Roberts E; Miguel RN; Furmaniak J; Smith BR
Thyroid; 2006 Dec; 16(12):1195-206. PubMed ID: 17199429
[TBL] [Abstract][Full Text] [Related]
51. An inactivating mutation within the first extracellular loop of the thyrotropin receptor impedes normal posttranslational maturation of the extracellular domain.
Sura-Trueba S; Aumas C; Carre A; Durif S; Leger J; Polak M; de Roux N
Endocrinology; 2009 Feb; 150(2):1043-50. PubMed ID: 18927215
[TBL] [Abstract][Full Text] [Related]
52. Epitopes for thyroid stimulating and blocking autoantibodies on the extracellular domain of the human thyrotropin receptor.
Tahara K; Ishikawa N; Yamamoto K; Hirai A; Ito K; Tamura Y; Yoshida S; Saito Y; Kohn LD
Thyroid; 1997 Dec; 7(6):867-77. PubMed ID: 9459630
[TBL] [Abstract][Full Text] [Related]
53. Constitutive activation of cyclic AMP but not phosphatidylinositol signaling caused by four mutations in the 6th transmembrane helix of the human thyrotropin receptor.
Kosugi S; Shenker A; Mori T
FEBS Lett; 1994 Dec; 356(2-3):291-4. PubMed ID: 7805857
[TBL] [Abstract][Full Text] [Related]
54. Antibody protection reveals extended epitopes on the human TSH receptor.
Latif R; Teixeira A; Michalek K; Ali MR; Schlesinger M; Baliram R; Morshed SA; Davies TF
PLoS One; 2012; 7(9):e44669. PubMed ID: 22957097
[TBL] [Abstract][Full Text] [Related]
55. Novel information on the epitope of an inverse agonist monoclonal antibody provides insight into the structure of the TSH receptor.
Chen CR; Salazar LM; McLachlan SM; Rapoport B
PLoS One; 2012; 7(2):e31973. PubMed ID: 22359649
[TBL] [Abstract][Full Text] [Related]
56. Signaling-sensitive amino acids surround the allosteric ligand binding site of the thyrotropin receptor.
Kleinau G; Haas AK; Neumann S; Worth CL; Hoyer I; Furkert J; Rutz C; Gershengorn MC; Schülein R; Krause G
FASEB J; 2010 Jul; 24(7):2347-54. PubMed ID: 20179143
[TBL] [Abstract][Full Text] [Related]
57. Thyrotropin receptor cleavage at site 1 does not involve a specific amino acid motif but instead depends on the presence of the unique, 50 amino acid insertion.
Tanaka K; Chazenbalk GD; McLachlan SM; Rapoport B
J Biol Chem; 1998 Jan; 273(4):1959-63. PubMed ID: 9442031
[TBL] [Abstract][Full Text] [Related]
58. Mutations that silence constitutive signaling activity in the allosteric ligand-binding site of the thyrotropin receptor.
Haas AK; Kleinau G; Hoyer I; Neumann S; Furkert J; Rutz C; Schülein R; Gershengorn MC; Krause G
Cell Mol Life Sci; 2011 Jan; 68(1):159-67. PubMed ID: 20652618
[TBL] [Abstract][Full Text] [Related]
59. The full-length TSH receptor is stabilized by TSH ligand.
Mezei M; Latif R; Davies TF
J Mol Graph Model; 2024 Jun; 129():108725. PubMed ID: 38373379
[TBL] [Abstract][Full Text] [Related]
60. Evidence that the C terminus of the A subunit suppresses thyrotropin receptor constitutive activity.
Chen CR; Chazenbalk GD; McLachlan SM; Rapoport B
Endocrinology; 2003 Sep; 144(9):3821-7. PubMed ID: 12933653
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
